Gonna make this brief because I’m tired of seeing my self type. I had STMP heading into today from $90 and now find myself up 80% in the position. They re-struck a deal with USPS and smashed numbers. I suspect the stock is going over $200 soon. Therefore, I am not selling my shares.
All position of mine are 5% weighted.
I spent the balance of my day repositioning into new stocks, cleaning out some losers, and placing one hedge (SOXS) for a just in case scenario. I am richly up for the year and have the confidence to tell you now, unequivocally, that my style cannot be matched nor replicated. At some point during my lifetime I will attempt to create an algorithm to catch trading patterns the way I do in real life. Until then, you’re stuck with me, bragging about my wins like a teenager on this ridiculous trading blog.
I hope you’re all having as much fun as I am and I want you to keep some things in perspective, while looking at stocks trading lower. The Fed has all but eliminated the business cycle with their policies, so do not fret these sell offs. Instead, you should embrace them.
Good day.
If you enjoy the content at iBankCoin, please follow us on Twitter
“Therefore, I am not selling my shares.”
STMP: today’s earnings were lucky, but my hat goes off to you if this pays off further. Either way, *this* justifies your iron balls comment.
Also, while there are many profitable traders in this never-ending, gap-closing, plunge-recovering bull market, your quick trigger (win or lose) should distinguish you when the market turns and others are trying to catch falling knives.
Just noticed that you hit 20,000 blog posts recently (late Jan/early Feb), so congratualtions!
NumbersGame
Been a couple years at least since I last visited this joint. See not much has changed. Same five dudes commenting nonsense and some semi-interesting prose. I understand you moved to NC. Guess you have some good sense after all. Carry on.
Damn! Haven’t seen ya for a while man.
WuhanVirus linked to collaboration with North Carolina university / Nat Med.
21(15): 1508–1513.
UNC
Chapel Hill. Utilizing the SARS-CoV infectious clone, “we generated” and
characterized “a chimeric virus” expressing the spike of bat coronavirus
SHC014. The results indicate that group 2b viruses encoding the SHC014
spike utilize multiple ACE2 receptors, “replicate efficiently in primary
human airway cells.”
“We synthetically rederived an infectious full length SHC014 recombinant
virus”
and demonstrate robust viral replication.
– Vineet D. Menachery – Boyd L. Yount – Jr, Rachel L. Graham
Departments of Epidemiology, University of North Carolina at Chapel Hill
– Kari Debbink – Scott H. Randell
Microbiology and Immunology, University of North Carolina at Chapel Hill
Department of Cell Biology and Physiology
– Xing-Yi Ge
Key Laboratory of Special Pathogens and Biosafety,
WUHAN INSTITUTE OF VIROLOGY, Chinese Academy of Sciences,
WUHAN, CHINA
– Zhengli-Li Shi
Key Laboratory of Special Pathogens and Biosafety,
WUHAN INSTITUTE OF VIROLOGY, Chinese Academy of Sciences,
WUHAN, CHINA
SARS-like cluster
of circulating bat
coronavirus pose
threat for human emergence
Freaky Friday
Any thoughts on SDGR?
Good that you kept that hedge…